The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

In the past, the Tesla CEO voiced his support for weight-loss drugs like Ozempic in an effort to tackle the nation's rising ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

Another clinical trial has found that SIGA Technologies' antiviral drug tecovirimat is ineffective as a treatment for mpox, prompting the investigators to stop patient recruitment. The study by ...